About Sai Gluco Pharma Private Limited
Data last updated:
Sai Gluco Pharma Private Limited is a private limited company based in Vijayawada, Andhra Pradesh, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 11 August 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24232AP2010PTC069939.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Meka Venkateswara Rao and Lakshmipathi Raju Manthena.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.Ff.3 D.No.54 – 16 – 3/1B Opp: Loyola College Road No.1 Central Excise Colony, Vijayawada, Andhra Pradesh, India – 520008.
As per the financials filed for FY 2023, the company reported a revenue of ₹43,000, a growth of 7% compared to the previous year. For the same year it recorded a net loss of ₹1,600 (net margin -3.7%) and EBITDA of -₹34,600 (EBITDA margin -80.5%). Revenue has declined at a compounded annual rate (CAGR) of 5% over three years and 25% over five years.
As per MCA filings, the company has open charges of ₹3.35 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website saiglucopharma.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressPlot No.Ff.3 D.No.54 – 16 – 3/1B Opp: Loyola College Road No.1 Central Excise Colony, Vijayawada, Andhra Pradesh, India – 520008
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Sai Gluco Pharma Private Limited FY 2025 filings available
Sai Gluco Pharma Private Limited reported revenue of ₹43,000 (up 7% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Sai Gluco Pharma Private Limited
Revenue rose 7% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 25%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sai Gluco Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | ₹43,000 | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹34,600 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1,600 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sai Gluco Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -80.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sai Gluco Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Sai Gluco Pharma Private Limited
Sai Gluco Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Meka Venkateswara Rao Also directs: Kondapally Envirotech Private Limited | Director | 11 Aug 2010 | 16 Years 2 Months | Current |
| Lakshmipathi Raju Manthena | Director | 11 Aug 2010 | 16 Years 2 Months | Current |
| Meka Rajasekhar | Director | 11 Aug 2010 | 16 Years 2 Months | Current |
Auditor Details of Sai Gluco Pharma Private Limited
Sai Gluco Pharma Private Limited is audited by G RAMA RAO & CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| G RAMA RAO & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Sai Gluco Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sai Gluco Pharma Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Jul 2024 | Canara Bank | ₹3.35 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Sai Gluco Pharma Private Limited
Employment history and EPFO contributions of people linked to Sai Gluco Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sai Gluco Pharma Private Limited
Sai Gluco Pharma Private Limited has 5 board changes on record since 2010: 4 appointments and 1 cessation. The latest: Venkata Sai Babu Rangisetty ceased to be Director on 01 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Sai Gluco Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sai Gluco Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sai Gluco Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sai Gluco Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sai Gluco Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sai Gluco Pharma Private Limited
Sai Gluco Pharma is an active private limited company based in Vijayawada, Andhra Pradesh, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 11 August 2010 (16+ years old) and is registered under CIN U24232AP2010PTC069939.
Sai Gluco Pharma reported revenue of ₹43,000 for FY 2023 (up 7% YoY).
Sai Gluco Pharma has 3 current directors:
- Meka Venkateswara Rao - Director
- Lakshmipathi Raju Manthena - Director
- Meka Rajasekhar - Director
Sai Gluco Pharma reported a net loss of ₹1,600 (net margin -3.7%) and EBITDA of -₹34,600 (EBITDA margin -80.5%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sai Gluco Pharma is -5% over three years and -25% over five years. In the latest year (FY 2023) revenue rose 7%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Sai Gluco Pharma is U24232AP2010PTC069939. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sai Gluco Pharma was incorporated on 11 August 2010, making it 16+ years old. It is registered with the Registrar of Companies, Vijayawada.
Venkata Sai Babu Rangisetty ceased to be Director on 01 Feb 2024. Lakshmipathi Raju Manthena was appointed as Director on 11 Aug 2010. Meka Rajasekhar was appointed as Director on 11 Aug 2010. Sai Gluco Pharma has 5 board changes on record in total.
Sai Gluco Pharma can be reached through the website saiglucopharma.in. Its registered office is in Vijayawada, Andhra Pradesh, India.
The registered office of Sai Gluco Pharma is at Plot No.Ff.3 D.No.54 – 16 – 31B Opp: Loyola College Road No.1 Central Excise Colony, Vijayawada, Andhra Pradesh, India – 520008.